ANDA 30-Month Stay Of Approval Does Not Apply If Patent Case Is Settled

FDA is proposing to void the 30-month Waxman/ Hatch stay of ANDA approval in cases where patent litigation between the applicant and the innovator company is dismissed or settled.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet